News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
689,849 Results
Type
Article (39233)
Company Profile (282)
Press Release (650334)
Section
Business (203946)
Career Advice (1999)
Deals (35386)
Drug Delivery (89)
Drug Development (80885)
Employer Resources (168)
FDA (16112)
Job Trends (14815)
News (344730)
Policy (32456)
Tag
Academia (2530)
Alliances (49259)
Alzheimer's disease (1290)
Approvals (16078)
Artificial intelligence (160)
Bankruptcy (354)
Best Places to Work (11603)
Biotechnology (199)
Breast cancer (204)
Cancer (1518)
Cardiovascular disease (121)
Career advice (1665)
CAR-T (106)
Cell therapy (312)
Clinical research (64928)
Collaboration (566)
Compensation (307)
COVID-19 (2549)
C-suite (133)
Data (1467)
Diabetes (189)
Diagnostics (6197)
Earnings (85027)
Employer resources (146)
Events (110349)
Executive appointments (482)
FDA (16885)
Funding (513)
Gene therapy (214)
GLP-1 (621)
Government (4338)
Healthcare (18738)
Infectious disease (2646)
Inflammatory bowel disease (114)
Interviews (309)
IPO (16393)
Job creations (3625)
Job search strategy (1418)
Layoffs (424)
Legal (7871)
Lung cancer (225)
Manufacturing (214)
Medical device (13231)
Medtech (13236)
Mergers & acquisitions (19258)
Metabolic disorders (493)
Neuroscience (1651)
NextGen: Class of 2025 (6506)
Non-profit (4471)
Northern California (1863)
Obesity (281)
Opinion (186)
Patents (133)
People (56638)
Phase I (20208)
Phase II (28592)
Phase III (21304)
Pipeline (613)
Postmarket research (2561)
Preclinical (8554)
Radiopharmaceuticals (239)
Rare diseases (285)
Real estate (5893)
Regulatory (21783)
Research institute (2312)
Resumes & cover letters (349)
Southern California (1612)
Startups (3565)
United States (16612)
Vaccines (578)
Weight loss (194)
Date
Today (115)
Last 7 days (390)
Last 30 days (1954)
Last 365 days (34851)
2025 (1701)
2024 (35252)
2023 (40077)
2022 (51173)
2021 (55710)
2020 (54086)
2019 (46541)
2018 (35019)
2017 (32109)
2016 (31481)
2015 (37552)
2014 (31318)
2013 (26345)
2012 (28571)
2011 (29263)
2010 (27328)
Location
Africa (713)
Arizona (203)
Asia (37391)
Australia (6104)
California (4236)
Canada (1553)
China (361)
Colorado (190)
Connecticut (205)
Europe (80063)
Florida (605)
Georgia (147)
Illinois (413)
Indiana (242)
Maryland (685)
Massachusetts (3277)
Michigan (183)
Minnesota (316)
New Jersey (1183)
New York (1203)
North Carolina (784)
Northern California (1863)
Ohio (154)
Pennsylvania (999)
South America (1093)
Southern California (1612)
Texas (615)
Utah (119)
Washington State (428)
689,849 Results for "penumbra inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Penumbra, Inc. to Present at the 43rd Annual J.P. Morgan Healthcare Conference
December 31, 2024
·
1 min read
Biotech Bay
Penumbra, Inc. to Present at the Truist Securities MedTech Conference 2024
Penumbra, Inc. announced that its management team is scheduled to present at the Truist Securities MedTech Conference on Tuesday, June 18, 2024.
June 4, 2024
·
1 min read
Biotech Bay
Penumbra, Inc. to Present at the William Blair Growth Stock Conference
Penumbra, Inc. (NYSE: PEN) today announced that its management team is scheduled to present at the William Blair Growth Stock Conference on Thursday, June 6, 2024.
May 23, 2024
·
1 min read
Business
Penumbra, Inc. Reports First Quarter 2024 Financial Results
Penumbra, Inc. (NYSE: PEN), a global healthcare company focused on innovative therapies, today reported financial results for the first quarter ended March 31, 2024.
May 7, 2024
·
15 min read
Biotech Bay
Penumbra, Inc. to Present at the RBC Capital Markets Global Healthcare Conference
Penumbra, Inc. announced that its management team is scheduled to present at the RBC Capital Markets Global Healthcare Conference on Wednesday, May 15, 2024.
May 1, 2024
·
1 min read
Press Releases
Penumbra, Inc. Reports Third Quarter 2024 Financial Results
October 30, 2024
·
20 min read
Press Releases
Penumbra, Inc. Announces Completion of THUNDER IDE Study Enrollment for Acute Ischemic Stroke
October 15, 2024
·
4 min read
Business
Penumbra, Inc. to Present at the Baird Global Healthcare Conference
August 27, 2024
·
1 min read
Business
Penumbra, Inc. to Present at the Wells Fargo Healthcare Conference
August 22, 2024
·
1 min read
Business
Penumbra, Inc. Schedules First Quarter 2024 Earnings Release and Conference Call for May 7, 2024
Penumbra, Inc. (NYSE: PEN) today announced that it will host a conference call to discuss financial results for the first quarter 2024 after market close on Tuesday, May 7, 2024 at 4:30 PM Eastern Time.
April 9, 2024
·
1 min read
1 of 68,985
Next
